Today: 9 June 2026
StubHub stock holds near $9 in premarket after sharp Friday jump, earnings next in focus
23 February 2026
1 min read

StubHub stock holds near $9 in premarket after sharp Friday jump, earnings next in focus

NEW YORK, Feb 23, 2026, 08:52 EST — Premarket

  • StubHub Holdings (NYSE: STUB) hovered around $9.36 just before the bell, showing little movement.
  • Shares ended Friday with a jump of almost 10%, clawing back part of their recent losses.
  • March 4 results are on deck, with traders eyeing them for the next move.

StubHub Holdings traded around $9.36 ahead of Monday’s open, the stock flat in premarket as traders weighed last week’s rebound. No new company headlines landed before the U.S. cash session.

Shares in the ticket marketplace closed out Friday at $9.36, climbing 9.86% for the session, Yahoo Finance data show.

StubHub shares, though they’ve bounced, remain far under their September IPO price of $23.50. The stock’s still twitchy—watchers are alert for any sign that the post-IPO reset is leveling out.

That context goes a long way toward making sense of why analyst calls have been swinging the tape harder than normal. On Feb. 18, Citigroup took StubHub up to “Neutral” from “Sell,” slashing its target to $9. The firm cited valuation after a sharp selloff, plus what it described as regulatory and AI-related concerns. TipRanks

Jason Bazinet at Citi issued the upgrade, TheFly reported via TipRanks.

Craig-Hallum launched coverage on Jan. 29, assigning a “Hold” and a $12 target. Analysts pointed to StubHub’s regained North American share and the international push through viagogo, but highlighted lingering doubts about margin limits. For recent listings such as StubHub, EBITDA—the standard yardstick for cash flow—remains a sticking point. Investing.com

Eyes now turn to StubHub’s next big event: The company has penciled in March 4 to release its fourth-quarter and full-year 2025 numbers, right after the U.S. market wraps up. A conference call follows at 5 p.m. ET.

Legal trouble is hanging over the company, too. Investors have filed a securities class action in Manhattan federal court, targeting the firm’s IPO disclosures, a law firm update shows. Some are looking out for possible ripple effects in related filings and statements.

Bulls face a potential headache if the March report stirs up fresh questions over growth and take rates, all while scrutiny on ticket fees and resale tactics refuses to fade. Craig-Hallum isn’t convinced StubHub can keep grabbing market share and still “meaningfully expand” margins. TipRanks

Traders are watching March 4 for data and management remarks, looking for hints on 2026 demand or spending strategy. Webcast info is up at StubHub’s investor site.

Stock Market Today

  • Semiconductor Stock Poised to Surpass Micron Technology by 2028
    June 9, 2026, 10:18 AM EDT. Micron Technology has surged nearly 800% recently, driven by high demand and pricing power in memory chips, pushing its market cap past $1 trillion. However, analysts predict supply constraints easing by 2028 could cause earnings to peak and decline, potentially halving share value to around $517.50. Meanwhile, a major semiconductor competitor valued around $650 billion is expanding production, potentially surpassing Micron's value by 2028. The industry faces cyclical dynamics as new manufacturing capacity comes online globally, impacting pricing and earnings. Investors are watching these shifts closely for long-term positioning amid evolving chip supply and demand.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Visa stock set for Monday as Mexico blocks Prosa deal after the bell
Previous Story

Visa stock set for Monday as Mexico blocks Prosa deal after the bell

National Grid share price ticks up as Ofgem flags AI data-centre power crunch
Next Story

National Grid share price ticks up as Ofgem flags AI data-centre power crunch

Go toTop